Related Experiment Video
Updated: Aug 4, 2026

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
Published on: April 24, 2021
Long non-coding RNA MEG3 promotes cerebral ischemia-reperfusion injury through increasing pyroptosis by targeting
Ji Liang1, Qiang Wang1, Jun-Qi Li1
1Department of Neurology, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou 570208, Hainan Province, PR China.
Objective:
Inflammasome contributes to ischemic brain injury by inducing pyroptosis and inflammation. The aim of this study is to unravel the mechanism of long non-coding RNA (lncRNA) maternally expressed gene 3 (MEG3)-mediated regulation of absent in melanoma 2 (AIM2) inflammasome during cerebral ischemia/reperfusion (I/R).
Methods:
In vivo middle cerebral artery occlusion (MCAO) rat model and in vitro oxygen-glucose deprivation/reperfusion (OGD/R)-treated neurocytes model were generated. TTC, H&E staining and TUNEL were performed to assess the cerebral ischemic injury. LDH and MTT assays were used to detect cell viability and cytotoxicity. qRT-PCR was used to detect the expression levels of MEG3, miR-485 and AIM2. Immunohistochemistry (IHC) and immunofluorescence were conducted to detect the AIM2 expression. ELISA and Western blotting were performed to determine the secretion and protein levels of inflammasome signaling proteins. Dual luciferase reporter assay and Ago2-RIP were used to validate the direct interaction among MEG3, miR-485 and AIM2.
Results:
In both MCAO rats and OGD/R-treated neurocytes, MEG3 and AIM2 were significantly up-regulated, whereas miR-485 was down-regulated. MCAO induces pyroptosis and release of IL-1β and IL-18 in ischemia brain. MEG3 acted as a molecular sponge to suppress miR-485, and AIM2 was identified as a direct target of miR-485. Knockdown of MEG3 inhibited OGD/R-induced pyroptosis and inflammation, and lack of MEG3 inhibited caspase1 signaling and decreased the expression of AIM2, ASC, cleaved-caspase1 and GSDMD-N. While overexpression of MEG3 exerted opposite effects.
Conclusion:
MEG3/miR-485/AIM2 axis contributes to pyroptosis via activating caspase1 signaling during cerebral I/R, suggesting that this axis may be a potent therapeutic target in ischemic stroke.
Insights
Long non-coding RNA MEG3 promotes ischemic stroke by activating the AIM2 inflammasome. This pathway involves MEG3 sponging miR-485, which targets AIM2, leading to pyroptosis and inflammation.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Inflammasomes, particularly AIM2, are implicated in ischemic brain injury.
- Pyroptosis and inflammation are key pathological processes in cerebral ischemia/reperfusion (I/R).
- Long non-coding RNAs (lncRNAs) are emerging as critical regulators in various biological processes, including neurological disorders.
Purpose of the Study:
- To elucidate the regulatory mechanism of lncRNA MEG3 on the AIM2 inflammasome in cerebral I/R.
- To investigate the role of the MEG3/miR-485/AIM2 axis in pyroptosis and inflammation during cerebral I/R.
Main Methods:
- Established in vivo (MCAO) and in vitro (OGD/R) models of cerebral I/R.
- Assessed ischemic injury using TTC, H&E, and TUNEL assays.
- Quantified gene and protein expression of MEG3, miR-485, AIM2, and inflammasome components via qRT-PCR, IHC, immunofluorescence, ELISA, and Western blotting.
- Validated interactions using dual luciferase reporter and Ago2-RIP assays.
Main Results:
- MEG3 and AIM2 were upregulated, while miR-485 was downregulated in cerebral I/R models.
- MEG3 acted as a molecular sponge for miR-485, and AIM2 was a direct target of miR-485.
- MEG3 knockdown reduced OGD/R-induced pyroptosis and inflammation by inhibiting caspase-1 signaling and AIM2 expression.
Conclusions:
- The MEG3/miR-485/AIM2 axis promotes pyroptosis via caspase-1 activation in cerebral I/R.
- This axis represents a potential therapeutic target for ischemic stroke.
Related Concept Videos
MicroRNAs
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
MicroRNAs